131 related articles for article (PubMed ID: 34976999)
1. CPEB4 Inhibit Cell Proliferation via Upregulating p21 mRNA Stability in Renal Cell Carcinoma.
Di J; Wang H; Zhao Z; Zhao G; Qin X; Han Z; Liu Y
Front Cell Dev Biol; 2021; 9():687253. PubMed ID: 34976999
[TBL] [Abstract][Full Text] [Related]
2. Biphasic and Stage-Associated Expression of CPEB4 in Hepatocellular Carcinoma.
Tsai LY; Chang YW; Lee MC; Chang YC; Hwang PI; Huang YS; Cheng CF
PLoS One; 2016; 11(5):e0155025. PubMed ID: 27158894
[TBL] [Abstract][Full Text] [Related]
3. Targeted p21(WAF1/CIP1) activation by miR-1236 inhibits cell proliferation and correlates with favorable survival in renal cell carcinoma.
Wang C; Tang K; Li Z; Chen Z; Xu H; Ye Z
Urol Oncol; 2016 Feb; 34(2):59.e23-34. PubMed ID: 26421587
[TBL] [Abstract][Full Text] [Related]
4. CPEB4 is a candidate biomarker for defining metastatic cancers and directing personalized therapies.
Xu H; Liu B
Med Hypotheses; 2013 Nov; 81(5):875-7. PubMed ID: 24045092
[TBL] [Abstract][Full Text] [Related]
5. Expression of CPEB4 in invasive ductal breast carcinoma and its prognostic significance.
Sun HT; Wen X; Han T; Liu ZH; Li SB; Wang JG; Liu XP
Onco Targets Ther; 2015; 8():3499-506. PubMed ID: 26648741
[TBL] [Abstract][Full Text] [Related]
6. CPEB4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.
Wang HX; Qin R; Mao J; Huang QL; Hong F; Li F; Gong ZY; Xu T; Yan Y; Chao SH; Zhang SK; Chen JX
Clin Neurol Neurosurg; 2018 Jun; 169():92-97. PubMed ID: 29642043
[TBL] [Abstract][Full Text] [Related]
7. Downregulated cytoplasmic polyadenylation element-binding protein-4 is associated with the carcinogenesis of head and neck squamous cell carcinoma.
Zeng M; Li F; Wang L; Chen C; Huang X; Wu X; She W; Zhou L; Tao Z
Oncol Lett; 2018 Mar; 15(3):3226-3232. PubMed ID: 29435062
[TBL] [Abstract][Full Text] [Related]
8. High expression of cytoplasmic polyadenylation element-binding protein 4 correlates with poor prognosis of patients with colorectal cancer.
He X; Lin X; Cai M; Fan D; Chen X; Wang L; Wu X; Lan P; Wang J
Virchows Arch; 2017 Jan; 470(1):37-45. PubMed ID: 27771769
[TBL] [Abstract][Full Text] [Related]
9. [The research progress of CPEB4 in tumor].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jul; 32(13):1038-1033. PubMed ID: 29986574
[TBL] [Abstract][Full Text] [Related]
10. CPEB4 interacts with Vimentin and involves in progressive features and poor prognosis of patients with astrocytic tumors.
Chen W; Hu Z; Li XZ; Li JL; Xu XK; Li HG; Liu Y; Liu BH; Jia WH; Li FC
Tumour Biol; 2016 Apr; 37(4):5075-87. PubMed ID: 26546435
[TBL] [Abstract][Full Text] [Related]
11. CPEB4 immunohistochemical expression is associated to prognosis in stage IV colorectal carcinoma.
Cortés-Guiral D; Pastor-Iodate C; Díaz Del Arco C; Del Puerto-Nevado L; Fernández-Aceñero MJ
Pathol Res Pract; 2017 Jun; 213(6):639-642. PubMed ID: 28551384
[TBL] [Abstract][Full Text] [Related]
12. Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.
Calderone V; Gallego J; Fernandez-Miranda G; Garcia-Pras E; Maillo C; Berzigotti A; Mejias M; Bava FA; Angulo-Urarte A; Graupera M; Navarro P; Bosch J; Fernandez M; Mendez R
Gastroenterology; 2016 Apr; 150(4):982-97.e30. PubMed ID: 26627607
[TBL] [Abstract][Full Text] [Related]
13. CPEB4 promotes cell migration and invasion via upregulating Vimentin expression in breast cancer.
Lu R; Zhou Z; Yu W; Xia Y; Zhi X
Biochem Biophys Res Commun; 2017 Jul; 489(2):135-141. PubMed ID: 28536077
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA XIST regulates miR-106b-5p/P21 axis to suppress tumor progression in renal cell carcinoma.
Sun K; Jia Z; Duan R; Yan Z; Jin Z; Yan L; Li Q; Yang J
Biochem Biophys Res Commun; 2019 Mar; 510(3):416-420. PubMed ID: 30717973
[TBL] [Abstract][Full Text] [Related]
16. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.
Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic polyadenylation element-binding protein 4 is highly expressed in human glioma.
Hu H; Cong L; Liang C; Yang L; Guo E; Song J; Liu L; Lu S; Guo C; Wu Z; Ma S; Zhao Z; Wang L; Jiao B
Neuroreport; 2016 May; 27(8):593-9. PubMed ID: 27096214
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of CPEB4 expression suppresses cell migration and invasion via Akt pathway in non-small cell lung cancer.
Hu J; Zhang L; Chen Q; Lin J; Wang S; Liu R; Zhang W; Miao K; Shou T
Cell Biol Int; 2018 Nov; 42(11):1484-1491. PubMed ID: 29286212
[TBL] [Abstract][Full Text] [Related]
19. MiR-216a exerts tumor-suppressing functions in renal cell carcinoma by targeting TLR4.
Wang W; Zhao E; Yu Y; Geng B; Zhang W; Li X
Am J Cancer Res; 2018; 8(3):476-488. PubMed ID: 29637002
[TBL] [Abstract][Full Text] [Related]
20. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
